Evidence map›Paper›PMID 34723044›Full record

ArticleScience immunology2021

All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages.

Enyu Rao, Yuzhu Hou, Xiaona Huang, Liangliang Wang, Jiaai Wang, Wenxin Zheng, Hengjin Yang, Xinshuang Yu, Kaiting Yang, Jason Bugno and 5 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Radiotherapy and immunology.The Journal of experimental medicine · 2024
    Review
  20. Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Enyu RaoCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yuzhu HouLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Xiaona HuangLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Liangliang WangLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Jiaai WangLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Wenxin ZhengLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Hengjin YangCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xinshuang YuDepartment of Oncology, First Affiliated Hospital with Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong, 250014, China.
Kaiting YangLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Jason BugnoCommittee on Clinical Pharmacology and Pharmacogenomics, University of Chicago.
Xingchen DingDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250014, China.
Everett VokesDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Yang-Xin FuDepartment of Pathology, University of Texas Southwest Medical Center, Dallas, TX, USA.
Ralph R WeichselbaumLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Hua L LiangLudwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
University of Chicago · USXuzhou Medical College · CNShandong First Medical University · CNShandong Provincial QianFoShan Hospital · CNThe University of Texas Southwestern Medical Center · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Radiation Effect on Immune Cells and the MicrobiomeU54CA274291 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joseph O Deasy, Silvia C. Formenti · 2022 to 2026
$9.1M
CLINICAL THERAPEUTICST32GM007019 · NIGMS · UNIVERSITY OF CHICAGO · PI Peter Hugh O'Donnell, MARK J RATAIN · 1985 to 2026
$8.7M
Enhancing the abscopal effect in cancer treatment by immune modulationR21CA195075 · NCI · UNIVERSITY OF CHICAGO · PI WEICHSELBAUM, RALPH R · 2016 to 2017
$378k
NCI NIH HHS P30 CA014599NCI NIH HHS R21 CA195075NCI NIH HHS U54 CA274291NIGMS NIH HHS T32 GM007019
6 · The paper itself

Abstract

Radiotherapy (RT) is an important anti-cancer treatment modality that activates innate and adaptive immune responses. When all-trans retinoic acid (RA) was administered with radiation, we observed superior antitumor responses compared to ionizing radiation (IR) alone or RA alone. The superior antitumor effects of combination treatment were accompanied by a dramatic increase of TNF-α- and inducible nitric oxide synthase (iNOS)-producing inflammatory macrophages in local and distal non-irradiated (distal) tumors. Inflammatory macrophages are essential for the therapeutic efficacy of combination treatment by inducing effector T cell infiltration and enhancing the effector T cell to regulatory T cell ratio in local and distal tumors. T cells and T cell-derived IFN-γ are crucial for increasing inflammatory macrophage levels in IR and RA treated tumors. Notably, whereas CD8

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorChemoradiotherapyDisease Models, AnimalHumansInterferon-gammaMacrophagesMiceMice, KnockoutNeoplasmsRadiation ToleranceReceptors, CCR2TretinoinTumor MicroenvironmentCcr2 protein, mouseIFNG protein, mouseInterferon-gammaReceptors, CCR2Tretinoin

Identifiers

PMID34723044
PMCPMC8550472
OpenAlexW3172655191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.